Concerns about the approval of nusinersen sodium by the US food and drug administration

Martha S. Gerrity; Vinay Prasad; Adam J. Obley

doi:10.1001/jamainternmed.2018.0869

Concerns about the approval of nusinersen sodium by the US food and drug administration

Martha S. Gerrity, Vinay Prasad, Adam J. Obley

Knight Cancer Institute

Research output: Contribution to journal › Comment/debate › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	743-744
Number of pages	2
Journal	JAMA internal medicine
Volume	178
Issue number	6
DOIs	https://doi.org/10.1001/jamainternmed.2018.0869
State	Published - Jun 2018

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1001/jamainternmed.2018.0869

Cite this

@article{a6aab1ed0c24442082d14a4306b1eda6,

title = "Concerns about the approval of nusinersen sodium by the US food and drug administration",

author = "Gerrity, {Martha S.} and Vinay Prasad and Obley, {Adam J.}",

year = "2018",

month = jun,

doi = "10.1001/jamainternmed.2018.0869",

language = "English (US)",

volume = "178",

pages = "743--744",

journal = "JAMA internal medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "6",

}

TY - JOUR

T1 - Concerns about the approval of nusinersen sodium by the US food and drug administration

AU - Gerrity, Martha S.

AU - Prasad, Vinay

AU - Obley, Adam J.

PY - 2018/6

Y1 - 2018/6

UR - http://www.scopus.com/inward/record.url?scp=85048803243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048803243&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2018.0869

DO - 10.1001/jamainternmed.2018.0869

M3 - Comment/debate

C2 - 29710299

AN - SCOPUS:85048803243

SN - 2168-6106

VL - 178

SP - 743

EP - 744

JO - JAMA internal medicine

JF - JAMA internal medicine

IS - 6

ER -

Concerns about the approval of nusinersen sodium by the US food and drug administration

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this